Key Metrics 
10 Yrs X-Ray 
Valuation 
Analyst Note 
Qtr. Results 
Financials 
News 
About
HPC Biosciences Ltd (535217)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 535217 NSE: Agriculture | Small Cap | HPC Biosciences Share Price
₹25.68 0.00 (0.00%)
As on 29-Jul'24 16:01
HPC Biosciences Ltd (535217)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 535217 NSE: Agriculture | Small Cap | HPC Biosciences Share Price
₹25.68 0.00 (0.00%)
As on 29-Jul'24 16:01
Key Metrics
Valuation Multiples
Market Cap
₹410 Cr.
Current Price
₹25.7
52-Week Low / High
₹26 / 26
TTM EPS
-
TTM Sales
-
Book Value per Share
-
P/E Ratio
Industry PE
15.5
Price to Book (P/B)
Price to Sales (P/S)
EV/EBITDA
Dividend Yield
0%
Profitability Efficiency
Return on Equity (ROE)
%
Return on Capital Employed (ROCE)
%
Return on Assets (ROA)
%
Operating Profit Margin
0%
Net Profit Margin
-%
Gross Profit Margin
0%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
90.83%
Operating Profit Growth (1 Year)
-
-
Net Profit Growth (1 Year)
-
-
Asset Quality
Promoter Holding
21.93%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
-
Equity
₹16 Cr.
Face Value
₹1
All Time Low / High
₹3.73 / 75.75
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
HPC Biosciences Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good
Value Creation ⓘ
| Mar'12 | Mar'13 | Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | 125% | 18.4% | 4.5% | 2.6% | 1.7% | 1.9% | 0.8% | 1.9% | 1.1% | 3.7% | - |
| Value Creation Index ⓘ | 7.9 | 0.3 | -0.7 | -0.8 | -0.9 | -0.9 | -0.9 | -0.9 | -0.9 | -0.7 | - |
Growth Parameters ⓘ |
|||||||||||
| Sales ⓘ | 2.9 | 4.8 | 3.5 | 3.1 | 1.9 | 2.3 | 2 | 1.6 | 1.2 | 2.3 | 0 |
| Sales YoY Gr. | - | 64.1% | -27.3% | -10.7% | -39.5% | 20.9% | -13.7% | -18% | -25% | 90.8% | - |
| Adj EPS ⓘ | 0.9 | 0.2 | 0.1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.1 | 0 |
| YoY Gr. | - | -78.2% | -57.9% | -50% | -25% | 0% | -66.7% | 200% | -33.3% | 250% | - |
| BVPS (₹) ⓘ | 1.4 | 1.7 | 1.8 | 1.8 | 1.9 | 1.9 | 1.9 | 2 | 2 | 2.1 | 2.1 |
| Adj Net Profit ⓘ | 3.1 | 3 | 1.2 | 0.7 | 0.5 | 0.5 | 0.2 | 0.6 | 0.3 | 1.2 | 0 |
| Cash Flow from Ops. ⓘ | -0.4 | 3.4 | 4 | 0.2 | -0.2 | 1.1 | 0.1 | 1.2 | 0.8 | 1.4 | - |
| Debt/CF from Ops. ⓘ | 0 | 0 | 0.1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | -2.6% | 4.1% | 5.5% | 90.8% | ||||
| Adj EPS ⓘ | -24.4% | 18.5% | 91.3% | 250% | ||||
| BVPSⓘ | 4.6% | 2% | 2.2% | 3.5% | ||||
| Share Price | -6.5% | -0.6% | -0.7% | - | ||||
Key Financial Parameters ⓘ
| Mar'12 | Mar'13 | Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | 125.8 | 18.3 | 4.4 | 2.4 | 1.5 | 1.7 | 0.6 | 1.8 | 1.1 | 3.6 | 0 |
| Op. Profit Mgn % ⓘ | 109.6 | 90.3 | 73.7 | 64.6 | 93.8 | 60.9 | 48.5 | 75.3 | 72.3 | 70.8 | 77.6 |
| Net Profit Mgn % ⓘ | 105.2 | 62.5 | 35.7 | 22.8 | 24.7 | 22.5 | 10.1 | 34.6 | 28.1 | 51.2 | 0 |
| Debt to Equity ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Working Cap Days ⓘ | 228 | 667 | 1,587 | 2,145 | 4,122 | 3,788 | 4,763 | 6,058 | 8,382 | 4,584 | 1,058 |
| Cash Conv. Cycle ⓘ | 71 | 125 | 156 | 205 | 701 | 778 | 1,049 | 1,398 | 1,887 | 996 | 1,038 |
Valuation of HPC Biosciences - Consolidated
Analyst's Notes
No data found!
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
* Pledged shares as % of Promoter's holding (%)
Financials
No data found!
No data found!
No data found!
No data found!
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
HPC Biosciences Ltd FAQs
The current trading price of HPC Biosciences on 29-Jul-2024 16:01 is ₹25.68.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 28-Jul-2024 the market cap of HPC Biosciences stood at ₹409.9 Cr
The latest P/E ratio of HPC Biosciences as of 28-Jul-2024 is 0.00.
The latest P/B ratio of HPC Biosciences as of 28-Jul-2024 is 12.48.
The 52-week high of HPC Biosciences is ₹25.68 and the 52-week low is ₹25.68.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of HPC Biosciences is ₹0.21 ( Cr.) .
Past 10 year's financial track record analysis by Moneyworks4me indicates that HPC Biosciences Ltd is a average quality company.
The key valuation ratios of HPC Biosciences Ltd's currently when compared to its past seem to suggest it is in the Somewhat Undervalued zone.
No data found
About HPC Biosciences Ltd
No data to display
You have 44 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
